Small-molecule signaling modulator · BEGINNER LESSON
Purmorphamine
Purmorphamine is a synthetic small molecule from the purine class that activates the Smoothened (SMO) receptor and turns on Sonic Hedgehog (Shh) signaling. It is described as an SMO agonist and has been studied as a tool compound in preclinical models.
What it is and what is measured
Purmorphamine (often abbreviated PUR) is a chemical compound, not a gene or protein. Its structure is a trisubstituted purine, and the sources describe it as a small-molecule SMO receptor agonist. In experiments, researchers measure whether PUR activates SMO and downstream Shh signaling, and in animal or cell models they also measure outcomes such as gene expression, cell differentiation, injury size, inflammation, synaptic proteins, and behavior.
[1] The Therapeutic Potential of Purmorphamine Across Disease ... [2] purmorphamine (CHEBI:63053)
How it works
In the Shh pathway, the ligand Sonic Hedgehog normally binds Patched1 (PTCH1), which removes inhibition from SMO. SMO then helps activate GLI transcription factors, which are proteins that enter the nucleus and change gene expression. PUR can bypass the need for the natural Shh ligand by directly binding and activating SMO. The sources also describe canonical Shh signaling through GLI-mediated transcription and non-canonical Shh actions that do not rely only on that route.
[1] The Therapeutic Potential of Purmorphamine Across Disease ... [3] Purmorphamine Attenuates Neuro-Inflammation and Synaptic ...
What scientists observed in models
Across preclinical studies, PUR has been associated with osteoblast differentiation, protection in hypoxic-ischemic neonatal mouse brain injury, reduced neuroinflammation and oxidative stress, preservation of synaptic markers such as synaptophysin and PSD-95, and improved learning-related outcomes in mice. These findings are model-based, so they show biological activity in cells or animals rather than proven benefit in humans.
[1] The Therapeutic Potential of Purmorphamine Across Disease ... [3] Purmorphamine Attenuates Neuro-Inflammation and Synaptic ...
Limitations and caution
The evidence in the supplied sources is preclinical, and one review notes that PUR’s effects may reflect both compound-specific actions and the broader effects of SMO-Shh activation. The sources also say its neurological effects are not yet fully resolved mechanistically, and no clinical trials are registered in the cited summary. That means the mechanism is useful and studied, but not completely settled for every reported outcome.
[1] The Therapeutic Potential of Purmorphamine Across Disease ... [2] purmorphamine (CHEBI:63053) [3] Purmorphamine Attenuates Neuro-Inflammation and Synaptic ...
SEE THE IDEA
How purmorphamine acts in the Shh pathway
Synthetic small molecule
Receptor activated directly by PUR
Enter the nucleus and alter gene expression
Cell differentiation, reduced injury, lower inflammation
Purmorphamine activates SMO, which relays a signaling cascade to GLI factors and then changes gene expression and cell behavior.
A direct chemical activator can switch on the Shh pathway without the normal ligand binding step.
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.